Oxycodone and Aspirin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Oxycodone and Aspirin drug offered from Actavis Pharma, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Oxycodone and Aspirin |
| SUBSTANCE NAME: | OXYCODONE HYDROCHLORIDE; ASPIRIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-10-18 |
| END MARKETING DATE: | 0000-00-00 |
Oxycodone and Aspirin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Oxycodone and Aspirin from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 4.8355; 325(mg/1; mg/1) |
| START MARKETING DATE: | 2011-10-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3551_1839e730-75d3-49b5-a8af-c02f0573cbbd |
| PRODUCT NDC: | 0591-3551 |
| APPLICATION NUMBER: | ANDA090084 |
Other OXYCODONE HYDROCHLORIDE; ASPIRIN Pharmaceutical Manufacturers / Labelers:
